Table 2.
Organism (Study) | Tumor type | miRNAs | Alteration type | Known miRNA functions in the skeletal muscle |
---|---|---|---|---|
Human (Narasimhan et al. (150)) |
Pancreatic and colon cancer | let-7d-3p, miR-199a-3p, miR-345-5p, miR-423-5p, miR-423-3p, and miR-532-5p, miR-1296-5p, miR-3184-3p | Upregulated | None |
Human (Van de Worp et al. (151)) |
Non-small cell lung cancer | miR-335-3p, miR-424-5p, miR-424-3p, miR-450a-5p, miR-450b-5p | Upregulated | None |
miR-15b-5p, miR-20a-3p, miR-26a-2-3p, miR-103-3p, miR-144-5p, miR-370-3p, miR-379-5p, mir-409-3p, miR-451a, miR-483-5p, miR-483-3p, miR-485-3p, miR-512-3p, miR-517a-3p, miR-517c-3p, miR-518b, miR-519a-3p, miR-520g-3p, miR-520h, miR-522-3p, miR-656-3p, miR-766-3p, miR-1255b | Downregulated | miR-15b-5p negatively modulates myogenesis and cell proliferation; promotes muscle stem cell quiescence; modulates mitochondrial-dependent apoptosis; downregulates the insulin-PI3K-AKT signaling. miR-451a inhibits myogenic differentiation; regulates lipid metabolism; regulates energetic state and mitochondrial activity. |
||
Mouse (Soraes et al. (152)) |
C26 colon carcinoma | miR-133a-3p, miR-140, miR-489, miR-519e, miR-7029 | Upregulated | miR-133a-3p modulates myogenesis; regulates cytoskeletal organization. |
Let-7f-5p, let-7g-5p, let-7i-5p, miR-1-3p, miR-15a-5p, miR-15b-5p, miR-23a-3p, miR-23b-3p, miR-24-3p, miR-26b-5p, miR-27a-3p, miR-27b-3p, miR-143-3p, miR-195a-5p, miR-199a-3p, miR-422b-3p, miR-497a-5p | Downregulated | miR-1-3p promotes myogenesis and prevents proliferation; regulates cytoskeletal organization and chromatin structure. miR-15a/b-5p negatively modulate myogenesis and cell proliferation; promote muscle stem cell quiescence; modulate mitochondrial-dependent apoptosis; downregulate the insulin-PI3K-Akt signaling. miRNAs of the miR-23a/b clusters prevent muscle atrophy; promote muscle hypertrophy; modulate myogenic gene expression; modulate mitochondrial acticity. miR-143-3p downregulates glycolysis. |
||
Mouse (Lee et al. (153)) |
Lewis lung cancer | miR-147-3p, miR-205-5p, miR-223-3p, miR-511-3p | Upregulated | None |
miR-229a-3p, miR-431-5p, miR-665-3p, miR-1933-3p, miR-3473d | Downregulated | None | ||
Mouse (Fernandez et al. (154)) |
Lewis lung cancer | miR-144-5p, miR-144-3p, miR-181c-3p; miR-379-3p, miR-451a | Upregulated | miR-144-3p reduces glucose uptake and glycolysis; modulates the insulin-PI3K-Akt signaling; indirectly influences the mitochondrial activity. miR-181c-3p promotes myoblast differentiation. miR-451a inhibits myogenic differentiation; regulates lipid metabolism; regulates energetic state and mitochondrial activity. |
miR-10b-5p, miR-29b-3p, miR-146a-5p, miR-146b-5p, miR-183-5p, miR-223-3p, miR-338-5p, miR-350-3p, miR-382-5p, miR-671-3p, 1249-3p, miR-1843a-3p, miR-3535 | Downregulated | miR-29b-3p promotes myoblast differentiation and prevents cell cycle progression. |